Ohm - do you discount the possibility of accelerat
Post# of 148111
(Total Views: 375)
Posted On: 10/29/2024 3:32:51 PM
Quote:
Ohm - do you discount the possibility of accelerated approval for mssCRC? If it is a viable path, we'd have to initiate the phase 3 ahead of an FDA decision.
Or are you making a case to prioritize Alzheimer's regardless, pending of course good results from the pilot study?
Much less likely an early approval for mssCRC since there are existing drugs. But Alzheimer's should be prioritized because the revenue allows us to launch multiple large trials at once.
(12)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼